Skip to content

Laminectomy without or with dorsal Fusion for cervical myeloradiculopathy: a randomised trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN72800446
Enrollment
60
Registered
2007-06-11
Start date
2007-01-09
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cervical myelopathy due to cervical spinal stenosis Musculoskeletal Diseases Dorsopathies

Interventions

Laminectomy versus laminectomy and fusion.

Sponsors

Radboud University Nijmegen (The Netherlands)
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients with a minimal age of 60 years 2. At neurologic examination myelopathic changes must be apparent 3. At Magnetic Resonance Imaging (MRI), concordant stenotic alterations at the cervical level(s) must be present 4. At the plain sitting lateral radiograph a lordotic spine must be shown 5. The shape of the cervical spine is lordotic when the vertebral bodies of C3 to C6 are in front of a line drawn from a point of the posterior inferior part of C2 to a point at the posterior superior part of C7

Exclusion criteria

Exclusion criteria: 1. Previous cervical surgery for myelopathic signs and symptoms 2. Solely radiculopathy, or most important complaint 3. Unable to undergo MRI 4. Life expectancy less than two years 5. Other diseases interfering with neurologic symptoms and signs, for example spinal cord glioma, thoracic herniated disc with spinal cord compression, multiple sclerosis etc. 6. Rheumatoid arthritis 7. Trauma to the neck in history 8. Diseases interfering with rehabilitation, for example severe cardiac congestive disease 9. Participation in another study

Design outcomes

Primary

MeasureTime frame
Clinical outcome measured by the modified version of the Japanese Orthopedics Association scale (mJOA) score. This will be measured at six weeks, three months and one year after surgery.

Secondary

MeasureTime frame
1. Quality of life, measured using the 36-item Short Form health survey (SF-36) 2. Complications 3. Costs These will be measured at six weeks, three months and one year after surgery.

Countries

Netherlands

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Apr 6, 2026